A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Clinical trial NCT00453362 · COMPLETED
Trial details
- NCT number
- NCT00453362
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2010-04-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.